BioEcho Life Sciences GmbH
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BioEcho Life Sciences GmbH - overview
Established
2016
Location
Cologne, -, Germany
Primary Industry
Biotechnology
About
Based in Cologne, Germany, and founded in 2016 by Markus Müller and Frank Schäfer, BioEcho Life Sciences GmbH operates as a provider of nucleic acid sample preparation tools that are primarily used in clinical, biotech, life sciences research, agricultural, and industrial applications. In March 2022, Ampersand Capital Partners invested in BioEcho Life Sciences GmbH. The products of the company include EchoLUTION Viral RNA/DNA extraction kits, EchoLUTION DNA extraction kits, EchoCLEAN nucleic acid cleanup kits, EchoSAFE buffers and reagents, and lab tools. The company plans to use the funds received in March 2022 towards the expansion of its direct salesforce, commercial and geographic presence, and further growth plans.
Current Investors
Ampersand
Primary Industry
Biotechnology
Sub Industries
Bioinformatics
Website
www.bioecho.de
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only
BioEcho Life Sciences GmbH - timeline of key events
BioEcho Life Sciences GmbH - financials
| Fiscal Year Ended | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|
| Revenue (USD) | 16,858,000 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - |
| EBITDA (USD) | 8,356,132.1 | - | - | - |
| Operating Income (USD) | 8,224,066.3 | - | - | - |
| Operating Margin | 48.8% | - | - | - |
| % EBITDA Margin | 49.6% | - | - | - |
| NET Income (USD) | 5,358,461.3 | - | - | - |
| % Net Margin | 31.8% | - | - | - |
BioEcho Life Sciences GmbH - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth | Completed | BioEcho Life Sciences GmbH | - |
Displaying 1 - 1 of 1
BioEcho Life Sciences GmbH - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.